Showing 1 - 10 results of 10 for search 'Kara L. Vine', query time: 0.05s Refine Results
  1. 1
    N-Alkyl-Substituted Isatins Enhance P2X7 Receptor-Induced Interleukin-1β Release from Murine Macrophages

    N-Alkyl-Substituted Isatins Enhance P2X7 Receptor-Induced Interleukin-1β Release from Murine Macrophages by Ronald Sluyter, Kara L. Vine

    Published 2016-01-01
    Get full text
    Article
  2. 2
    <i>N</i>-Alkylisatin-Loaded Liposomes Target the Urokinase Plasminogen Activator System in Breast Cancer

    <i>N</i>-Alkylisatin-Loaded Liposomes Target the Urokinase Plasminogen Activator System in Breast Cancer by Lisa Belfiore, Darren N. Saunders, Marie Ranson, Kara L. Vine

    Published 2020-07-01
    Get full text
    Article
  3. 3
    Implantable coaxial nanocomposite biofibers for local chemo‐photothermal combinational cancer therapy

    Implantable coaxial nanocomposite biofibers for local chemo‐photothermal combinational cancer therapy by Hanghang Liu, Sepehr Talebian, Kara L. Vine, Zhen Li, Javad Foroughi

    Published 2022-01-01
    Get full text
    Article
  4. 4
    Improving the Delivery of SOD1 Antisense Oligonucleotides to Motor Neurons Using Calcium Phosphate-Lipid Nanoparticles

    Improving the Delivery of SOD1 Antisense Oligonucleotides to Motor Neurons Using Calcium Phosphate-Lipid Nanoparticles by Liyu Chen, Liyu Chen, Clare Watson, Clare Watson, Marco Morsch, Nicholas J. Cole, Roger S. Chung, Darren N. Saunders, Justin J. Yerbury, Kara L. Vine, Kara L. Vine

    Published 2017-08-01
    Get full text
    Article
  5. 5
    N-alkylated isatins evade P-gp mediated efflux and retain potency in MDR cancer cell lines

    N-alkylated isatins evade P-gp mediated efflux and retain potency in MDR cancer cell lines by Kara L. Vine, Lisa Belfiore, Luke Jones, Julie M. Locke, Samantha Wade, Elahe Minaei, Marie Ranson

    Published 2016-01-01
    Get full text
    Article
  6. 6
    Graft‐versus‐leukaemia immunity is retained following treatment with post‐transplant cyclophosphamide alone or combined with tocilizumab in humanised mice

    Graft‐versus‐leukaemia immunity is retained following treatment with post‐transplant cyclophosphamide alone or combined with tocilizumab in humanised mice by Chloe Sligar, Ellie Reilly, Peter Cuthbertson, Kara L Vine, Katrina M Bird, Amal Elhage, Stephen I Alexander, Ronald Sluyter, Debbie Watson

    Published 2024-01-01
    Get full text
    Article
  7. 7
    Examining the efficacy of localised gemcitabine therapy for the treatment of pancreatic cancer using a hybrid agent-based model.

    Examining the efficacy of localised gemcitabine therapy for the treatment of pancreatic cancer using a hybrid agent-based model. by Adrianne L Jenner, Wayne Kelly, Michael Dallaston, Robyn Araujo, Isobelle Parfitt, Dominic Steinitz, Pantea Pooladvand, Peter S Kim, Samantha J Wade, Kara L Vine

    Published 2023-01-01
    Get full text
    Article
  8. 8
    N-alkylisatin-based microtubule destabilizers bind to the colchicine site on tubulin and retain efficacy in drug resistant acute lymphoblastic leukemia cell lines with less in vitro neurotoxicity

    N-alkylisatin-based microtubule destabilizers bind to the colchicine site on tubulin and retain efficacy in drug resistant acute lymphoblastic leukemia cell lines with less in vitr... by Bryce Keenan, Rocio K. Finol-Urdaneta, Ashleigh Hope, John B. Bremner, Maria Kavallaris, Daniel Lucena-Agell, María Ángela Oliva, Jose Fernando Díaz, Kara L. Vine

    Published 2020-05-01
    Get full text
    Article
  9. 9
    Ubiquitin Homeostasis Is Disrupted in TDP-43 and FUS Cell Models of ALS

    Ubiquitin Homeostasis Is Disrupted in TDP-43 and FUS Cell Models of ALS by Natalie E. Farrawell, Luke McAlary, Jeremy S. Lum, Christen G. Chisholm, Sadaf T. Warraich, Ian P. Blair, Kara L. Vine, Darren N. Saunders, Justin J. Yerbury

    Published 2020-11-01
    Get full text
    Article
  10. 10
    CuATSM improves motor function and extends survival but is not tolerated at a high dose in SOD1 G93A mice with a C57BL/6 background

    CuATSM improves motor function and extends survival but is not tolerated at a high dose in SOD1 G93A mice with a C57BL/6 background by Jeremy S. Lum, Mikayla L. Brown, Natalie E. Farrawell, Luke McAlary, Diane Ly, Christen G. Chisholm, Josh Snow, Kara L. Vine, Tim Karl, Fabian Kreilaus, Lachlan E. McInnes, Sara Nikseresht, Paul S. Donnelly, Peter J. Crouch, Justin J. Yerbury

    Published 2021-09-01
    Get full text
    Article

Search Tools: